🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this expanded access program is to provide VX-770 prior to i...
Status
Approved For Marketing
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT01381289
Treatments Being Tested
The study evaluates the long-term safety and efficacy of elexacaftor (ELX)/...
Status
Completed
Location
Telethon Kids Institute
Start Date
2021-01-11
Trial ID
NCT04545515
Treatments Being Tested
The study is a Phase 2 Study to establish the safety and efficacy of a drug...
Status
Completed
Location
UAB Lung Health Center
Start Date
2017-03-16
Trial ID
NCT03085485
Treatments Being Tested
To evaluate the clinical mechanisms of action in lung and extrapulmonary sy...
Status
Completed
Location
Multiple Locations
Start Date
2016-02
Trial ID
NCT02508207
Treatments Being Tested
This is a Phase 2, randomized, double-blind, placebo- and tezacaftor/ivacaf...
Status
Completed
Location
Yale New Haven Hospital
Start Date
2017-08-08
Trial ID
NCT03224351
This study was evaluate the effect of elexacaftor (ELX)/tezacaftor (TEZ)/iv...
Status
Completed
Location
Royal Adelaide Hospital
Start Date
2021-01-15
Trial ID
NCT04599465
Treatments Being Tested
This two-part study will assess, in healthy volunteers, under both fasted a...
Status
Completed
Location
CMAX
Start Date
2015-03
Trial ID
NCT02392702
The purpose of this study was to evaluate the safety and tolerability of iv...
Status
Completed
Location
University of Alabama Hospital
Start Date
2007-05
Trial ID
NCT00457821
Treatments Being Tested
The primary objective of the study was to evaluate the safety of long-term ...
Status
Completed
Location
Multiple Locations
Start Date
2010-07
Trial ID
NCT01117012
Treatments Being Tested
To evaluate the safety and efficacy of treatment with VX-371 with and witho...
Status
Completed
Location
Multiple Locations
Start Date
2016-08
Trial ID
NCT02871778
Treatments Being Tested